<DOC>
	<DOC>NCT01259791</DOC>
	<brief_summary>This study consists of a series of prospective, randomized placebo-controlled n of 1 trials to objectively evaluate the reproducibility of subjective and objective symptoms among patients with a history of statin-related myopathy.</brief_summary>
	<brief_title>Evaluation of Patients With Statin Myopathy Using an N of 1 Trial Design</brief_title>
	<detailed_description />
	<mesh_term>Muscular Diseases</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>history of muscle symptoms occuring within 3 weeks of starting a statin need for statin therapy to achieve LDL target according to the 2009 Canadian Lipid Guidelines willingness to retry statin therapy currently tolerant of statin therapy metabolic or inflammatory myopathy known neuropathy CK elevation &gt;3 times upper limit of normal (ULN) previously on a statin or history of rhabdomyolysis pregnant, breastfeeding, or wanting to become pregnant in the near future participation in another clinical trial other medical condition associated with decreased life span inability to adhere to stringent regimen unwilling to stop consumption of grapefruit juice Subset of 5 patients also completing neuromuscular testing: same as above same as above but also: angina III of IV decompensated heart failure history of orthopedic problems have any skin ulcers or other nonhealed skin areas or infections in the arm or leg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>